EP3389712
ANTIBODY MOLECULES TO PD-1 AND USES THEREOF
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
16.12.2016EP published:
10.4.2024EP application number:
16831788.1
EPO information:
European Patent Register
Max expiry date:
15.12.2036
Title in English:
ANTIBODY MOLECULES TO PD-1 AND USES THEREOFLanguage of the patent:
English
Timeline
Today
16.12.2016EP application
10.4.2024EP Publication
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056 Basel, CH
Inventor
Name:
BILIC, SanelaAddress:
Urbandale, IA 50323, US
Name:
HOWARD, Danny, Roland, Jr.Address:
East Hanover, NJ 07936-1080, US
Name:
CAMERON, John, ScottAddress:
Cambridge, MA 02139, US
Name:
DRANOFF, GlennAddress:
Cambridge, MA 02139, US
Priority
Number:
201562269044 PDate:
17.12.2015Country:
US
Number:
201662331371 PDate:
3.5.2016Country:
US
Number:
201662344784 PDate:
2.6.2016Country:
US
Number:
201662347331 PDate:
8.6.2016Country:
US
Number:
201662359781 PDate:
8.7.2016Country:
US
Number:
201662381384 PDate:
30.8.2016Country:
US
Number:
201662400787 PDate:
28.9.2016Country:
US
Number:
201662414128 PDate:
28.10.2016Country:
US
Number:
201662431846 PDate:
9.12.2016Country:
US
Classification
Categories:
A61K 45/06, A61P 35/00, C07K 16/28, A61K 39/00